ConvergeHEALTH by Deloitte is a Gold Member of the Foundation and the Dinner Sponsor for our 2015 Annual Meeting.
ConvergeHEALTH by Deloitte: Advancing Life Science Innovation and Value through End-to-End Evidence
The life sciences and health care sector is rapidly becoming more value-driven, collaborative, and empowered by opportunities to develop and commercialize more precise, personalized therapeutic interventions informed by learnings from across the health care ecosystem. Deloitte and ConvergeHEALTH are uniquely prepared to help life sciences organizations succeed in this new era. Our approach, consultative services and analytic solutions are based on the recognition that insights gleaned from clinical trial and open science platform genomic data, can inform and improve the performance of nearly every aspect of the life sciences sector – from translational research to portfolio development through post-market safety and outcomes and performance-based contracting in medicine. We work with leading life science organizations on end-to-end management of evidence to more effectively advance translational research; enable precise segmentation of patient populations for protocols; assess therapeutic market dynamics; and better understand and demonstrate comparative effectiveness, safety, and value by leveraging data across research, development, clinical, regulatory, and commercial settings.